121 related articles for article (PubMed ID: 1715833)
1. Therapeutic efficacy of interferon on HCV-RNA in chronic hepatitis C.
Kuroki T; Nishiguchi S; Ueda T; Yabusako T; Fukuda K; Takeda T; Kim K; Nakajima S; Shiomi S; Seki S
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():239-42. PubMed ID: 1715833
[TBL] [Abstract][Full Text] [Related]
2. Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course.
Arase Y; Ikeda K; Chayama K; Murashima N; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Kumada H
J Gastroenterol; 2000; 35(8):607-12. PubMed ID: 10955599
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
4. Interferon therapy for non-A, non-B chronic hepatitis.
Iino S; Hino K; Kondo T; Koike K; Yasuda K; Yotsuyanagi H; Kurokawa K
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():224-9. PubMed ID: 1653164
[TBL] [Abstract][Full Text] [Related]
5. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
Kakumu S; Yoshika K; Tanaka K; Higashi Y; Kurokawa S; Hirofuji H; Kusakabe A
J Med Virol; 1993 Sep; 41(1):65-70. PubMed ID: 8228941
[TBL] [Abstract][Full Text] [Related]
6. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
[TBL] [Abstract][Full Text] [Related]
7. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
Vogel W; Graziadei I; Umlauft F; Datz C; Hackl F; Allinger S; Grünewald K; Patsch J
Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
[TBL] [Abstract][Full Text] [Related]
8. Alanine aminotransferase and HCV-RNA responses following interferon therapy of HCV-RNA positive chronic hepatitis.
Arase Y; Kumada H; Chayama K; Tsubota A; Ikeda K; Saitoh S; Sakai Y; Matsumoto T; Kobayashi M
Gastroenterol Jpn; 1992 Oct; 27(5):646-51. PubMed ID: 1330798
[TBL] [Abstract][Full Text] [Related]
9. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.
Ampurdanés S; Olmedo E; Maluenda MD; Forns X; López-Labrador FX; Costa J; Sánchez-Tapias JM; de Anta MT; Rodés J
J Hepatol; 1996 Dec; 25(6):827-32. PubMed ID: 9007709
[TBL] [Abstract][Full Text] [Related]
10. Early negative tests for serum HCV RNA as a predictor of sustained response to interferon therapy in patients with chronic hepatitis C.
Marcellin P; Martinot M; Erlinger S
Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):237-8. PubMed ID: 9096422
[TBL] [Abstract][Full Text] [Related]
11. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
12. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment.
Weiland O; Zhang YY; Widell A
Scand J Infect Dis; 1993; 25(1):25-30. PubMed ID: 8384732
[TBL] [Abstract][Full Text] [Related]
13. Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin.
Tong MJ; Hwang SJ; Lefkowitz M; Lee SD; Co RL; Conrad A; Schmid P; Lo KJ
J Gastroenterol Hepatol; 1994; 9(6):587-91. PubMed ID: 7865717
[TBL] [Abstract][Full Text] [Related]
14. Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases.
Montalto G; Zignego AL; Ruggeri MI; Giannini C; Soresi M; Monti M; Carroccio A; Careccia G; Di Martino D; Giannelli F
Dig Dis Sci; 1997 Aug; 42(8):1703-7. PubMed ID: 9286237
[TBL] [Abstract][Full Text] [Related]
15. Effects of interferon-alpha on serum hepatitis C virus in patients with chronic hepatitis C.
Shibata M; Kumada T; Yamada M; Nakano S; Kudo T; Morishima T
Dig Dis Sci; 1993 Apr; 38(4):608-11. PubMed ID: 8384979
[TBL] [Abstract][Full Text] [Related]
16. How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? Tokyo-Chiba Hepatitis Research Group.
Shiratori Y; Kato N; Yoshida H; Imazeki F; Okano K; Yokosuka O; Omata M
J Gastroenterol Hepatol; 1999 Jan; 14(1):79-84. PubMed ID: 10029282
[TBL] [Abstract][Full Text] [Related]
17. Recombinant interferon-alfa therapy in children with chronic hepatitis C.
Bortolotti F; Giacchino R; Vajro P; Barbera C; Crivellaro C; Alberti A; Nebbia G; Zancan L; De Moliner L; Bertolini A
Hepatology; 1995 Dec; 22(6):1623-7. PubMed ID: 7489965
[TBL] [Abstract][Full Text] [Related]
18. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of hepatitis C virus RNA in liver tissue as a predictive marker of the response to interferon therapy in chronic hepatitis C.
Hasui T; Shimomura H; Tsuji H; Wato M; Tsuji T
Acta Med Okayama; 1994 Jun; 48(3):151-7. PubMed ID: 7524269
[TBL] [Abstract][Full Text] [Related]
20. Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.
Orito E; Mizokami M; Suzuki K; Ohba K; Ohno T; Mori M; Hayashi K; Kato K; Iino S; Lau JY
J Med Virol; 1995 Jun; 46(2):109-15. PubMed ID: 7636496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
